4//SEC Filing
Pharmstandard International S.A. 4
Accession 0001140361-17-040741
CIK 0001105533other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 3:48 PM ET
Size
7.3 KB
Accession
0001140361-17-040741
Insider Transaction Report
Form 4
Public Joint Stock Co Pharmstandard
10% Owner
Transactions
- Other
Common Stock
2017-10-31$795.96/sh−99,495$79,194,040→ 13,142,784 total(indirect: Pharmstandard International S.A. is a wholly owned subsidiary of Joint Stock Company Pharmstandard.)
Pharmstandard International S.A.
10% Owner
Transactions
- Other
Common Stock
2017-10-31$795.96/sh−99,495$79,194,040→ 13,142,784 total(indirect: Pharmstandard International S.A. is a wholly owned subsidiary of Joint Stock Company Pharmstandard.)
Footnotes (2)
- [F1]Shares transferred as partial payment pursuant to a service agreement with IBK Company Limited dated 16 September 2016.
- [F2]Pharmstandard International S.A. is a wholly owned subsidiary of Joint Stock Company Pharmstandard. As the parent entity, Joint Stock Company Pharmstandard has voting power over the shares of the Issuer held by Pharmstandard International S.A.
Documents
Issuer
ARGOS THERAPEUTICS INC
CIK 0001105533
Entity typeother
Related Parties
1- filerCIK 0001598762
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 3:48 PM ET
- Size
- 7.3 KB